Article

Orphan Drug Cost Controversy Highlights AJPB Week in Review

Author(s):

Davy James, Managing Editor

Top articles of the week from The American Journal of Pharmacy Benefits.

Related Videos
Related Content
NCCN 2025: Advancing Breast Cancer Risk Assessment and Prevention Strategies
April 1st 2025

NCCN 2025: Advancing Breast Cancer Risk Assessment and Prevention Strategies

Luke Halpern, Assistant Editor
Everything You Need to Know From the American College of Cardiology 2025 Scientific Session
April 1st 2025

Everything You Need to Know From the American College of Cardiology 2025 Scientific Session

Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPS-AQ Cardiology, CACP Aislinn Antrim, Managing Editor
Site Logo
April 1st 2025

Upcoming NCPA Items for Pharmacy Teams: Spring 2025

Pharmacy Focus: Integrating SBIRT in Pharmacies to Combat Substance Use Disorder
March 31st 2025

Pharmacy Focus: Integrating SBIRT in Pharmacies to Combat Substance Use Disorder

Luke Halpern, Assistant Editor
Making M3P Work for Your Pharmacy: A Guide to Streamlining Enrollment and Supporting Patients
April 1st 2025

Making M3P Work for Your Pharmacy: A Guide to Streamlining Enrollment and Supporting Patients

Jeff Pohler, RPh
Intravenous Immunoglobulin Plus Rituximab Effective Alternative Option for Refractory Autoimmune Disease Treatment
April 1st 2025

Intravenous Immunoglobulin Plus Rituximab Effective Alternative Option for Refractory Autoimmune Disease Treatment

Luke Halpern, Assistant Editor